As diabetes care continues to be a major focus, new treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a exciting generation in GLP-1 receptor agonist medications. While all seek https://bookmarkmiracle.com/story643610/retatrutid-vs-tirzepatide-vs-semaglutide-a-head-to-head-analysis